Back to RTW INVESTMENTS, LP

ACAD
Showing 8 of 16 quarters

Position history for RTW INVESTMENTS, LP's holdings in ACADIA PHARMACEUTICALS INC

RTW INVESTMENTS, LP holds 7.1M shares of ACAD (ACADIA PHARMACEUTICALS INC), worth $159M as of 2026-Q1. ACAD represents 1.6% of RTW INVESTMENTS, LP's portfolio.

Current Value

$159M

Current Shares

7.1M

Total Value Change

-$63.7M

Total Shares Change

-6.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Unchanged
7.1M
0.0%
$159M1.6%$22.50
0
2025-Q4
Unchanged
7.1M
0.0%
$190.8M1.9%$26.70
0
2025-Q3
Decreased
7.1M
-20.6%
$152.5M1.9%$21.32
0
2025-Q2
Increased
9M
+5.3%
$194M2.8%$22.12
55
2025-Q1
Decreased
8.5M
-1.9%
$141.9M2.2%$17.07
0
2024-Q4
Decreased
8.7M
-36.5%
$159.7M2.4%$16.69
0
2024-Q3
Unchanged
13.7M
0.0%
$210.8M3.1%$15.69
0
2024-Q2
Decreased
13.7M
-0.9%
$222.7M3.4%$16.25
0

Other major holders of ACAD: BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used